Literature DB >> 11583981

Matrix metalloproteinases: a role in the contraction of vitreo-retinal scar tissue.

C M Sheridan1, N L Occleston, P Hiscott, C H Kon, P T Khaw, I Grierson.   

Abstract

The most common cause of failure of retinal reattachment surgery is formation of fibrocellular contractile membranes on both surfaces of the neuroretina. This intraocular fibrosis, known as proliferative vitreoretinopathy, results in a blinding tractional retinal detachment because of the contractile nature of the membrane. Contractility is a cell-mediated event that is thought to be dependent on locomotion and adhesion to the extracellular matrix. Interactions between cells and the extracellular matrix can be influenced by matrix metalloproteinases (MMPs) and we investigated the role of MMPs in two in vitro models (two- and three-dimensional) of human retinal pigment epithelial (RPE) cell-mediated contraction. MMP activity was detected using enzyme-linked immunosorbent assays and zymography techniques that revealed MMP-1, -2, -3, and -9 positivity during the collagen matrix contraction assays. RPE-populated collagen matrix contraction (three-dimensional) was inhibited using a cocktail of anti-MMP antibodies and with Galardin (a broad-spectrum MMP inhibitor). Galardin inhibition was dose-dependent, reversible, and dependent on cell number. MMP inhibitors had no effect on contraction when RPEs were seeded on two-dimensional collagen matrices or on cellular adhesion to collagen type I. Our results suggest that MMP activity may be required for three-dimensional but not two-dimensional RPE-collagen matrix contraction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583981      PMCID: PMC1850496          DOI: 10.1016/S0002-9440(10)62540-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Non-vascular vitreoretinopathy: the cells and the cellular basis of contraction.

Authors:  I Grierson; A Mazure; P Hogg; P Hiscott; C Sheridan; D Wong
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

2.  Matrix metalloproteinase inhibitors: a structure-activity study.

Authors:  D E Levy; F Lapierre; W Liang; W Ye; C W Lange; X Li; D Grobelny; M Casabonne; D Tyrrell; K Holme; A Nadzan; R E Galardy
Journal:  J Med Chem       Date:  1998-01-15       Impact factor: 7.446

3.  Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation.

Authors:  L C Padgett; G M Lui; Z Werb; M M LaVail
Journal:  Exp Eye Res       Date:  1997-06       Impact factor: 3.467

4.  Cytokines cause cultured retinal pigment epithelial cells to secrete metalloproteinases and to contract collagen gels.

Authors:  R C Hunt; A Fox; V al Pakalnis; M M Sigel; W Kosnosky; P Choudhury; E P Black
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-10       Impact factor: 4.799

5.  Are excessive granulation tissue formation and retarded wound contraction due to decreased collagenase activity in wounds in tight-skin mice?

Authors:  M S Agren; P M Mertz
Journal:  Br J Dermatol       Date:  1994-09       Impact factor: 9.302

6.  Effects of pharmacological modulation of intracellular signalling systems on retinal pigment epithelial cell attachment to extracellular matrix proteins.

Authors:  M Wagner; M T Benson; I G Rennie; S MacNeil
Journal:  Curr Eye Res       Date:  1995-05       Impact factor: 2.424

7.  Cytokines and serum cause alpha 2 beta 1 integrin-mediated contraction of collagen gels by cultured retinal pigment epithelial cells.

Authors:  R C Hunt; V A Pakalnis; P Choudhury; E P Black
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-03       Impact factor: 4.799

8.  In vitro studies of the contractility of cell types involved in proliferative vitreoretinopathy.

Authors:  A Mazure; I Grierson
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-11       Impact factor: 4.799

9.  Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.

Authors:  J P Barletta; G Angella; K C Balch; H G Dimova; G A Stern; M T Moser; G B van Setten; G S Schultz
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-01       Impact factor: 4.799

10.  A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.

Authors:  C H Kon; N L Occleston; D Charteris; J Daniels; G W Aylward; P T Khaw
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-07       Impact factor: 4.799

View more
  17 in total

Review 1.  Basement membranes and artificial substrates in cell transplantation.

Authors:  Carl Sheridan; Rachel Williams; Ian Grierson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-20       Impact factor: 3.117

2.  Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment.

Authors:  Chrysanthos Symeonidis; Eudoxia Diza; Eleni Papakonstantinou; Efimia Souliou; George Karakiulakis; Stavros A Dimitrakos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-29       Impact factor: 3.117

3.  Matrix metalloproteinase inhibition delays wound healing and blocks the latent transforming growth factor-beta1-promoted myofibroblast formation and function.

Authors:  Ursula Mirastschijski; Reinhild Schnabel; Juliane Claes; Wolfgang Schneider; Magnus S Agren; Carol Haaksma; James J Tomasek
Journal:  Wound Repair Regen       Date:  2010-03-12       Impact factor: 3.617

4.  Mechanical force enhances MMP-2 activation via p38 signaling pathway in human retinal pigment epithelial cells.

Authors:  Xu Hou; Quan-Hong Han; Dan Hu; Lei Tian; Chang-Mei Guo; Hong-Jun Du; Peng Zhang; Yu-Sheng Wang; Yan-Nian Hui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-10       Impact factor: 3.117

5.  A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).

Authors:  Mark Brian Sherwood
Journal:  Trans Am Ophthalmol Soc       Date:  2006

6.  The genomic response of the retinal pigment epithelium to light damage and retinal detachment.

Authors:  Amir Rattner; Leila Toulabi; John Williams; Huimin Yu; Jeremy Nathans
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

7.  Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring.

Authors:  Julie T Daniels; Gregory S Schultz; Timothy D Blalock; Qian Garrett; Gary R Grotendorst; Nicholas M Dean; Peng T Khaw
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

8.  Differentiation potential of CD14+ monocytes into myofibroblasts in patients with systemic sclerosis.

Authors:  Nadine Binai; Steven O'Reilly; Bridget Griffiths; Jacob M van Laar; Thomas Hügle
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

9.  Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.

Authors:  Kyungsun Choi; Kihwang Lee; Seung-Wook Ryu; Minju Im; Koung Hoon Kook; Chulhee Choi
Journal:  Mol Vis       Date:  2012-04-21       Impact factor: 2.367

10.  Characterisation of ilomastat for prolonged ocular drug release.

Authors:  Gary Parkinson; Simon Gaisford; Qian Ru; Alastair Lockwood; Ashkan Khalili; Rose Sheridan; Peng T Khaw; Steve Brocchini; Hala M Fadda
Journal:  AAPS PharmSciTech       Date:  2012-08-18       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.